| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.05 |
| mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.05 |
| mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.05 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.06 |
| mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.06 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |